Pharmaceutical compositions are provided for the pharmacological treatment of breathing disorders and, more specifically, to compositions containing agents having serotonin receptor modulating activity for the alleviation of sleep apnea (central and obstructive) and other sleep-related breathing disorders wherein the active ingredients are released such as to extend effective blood plasma concentrations across the period of sleep.

 
Web www.patentalert.com

< Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor Modulators

> Combination of Organic Compounds

~ 00457